{"id":534138,"date":"2021-03-15T18:30:02","date_gmt":"2021-03-15T18:30:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=534138"},"modified":"2021-03-15T18:30:02","modified_gmt":"2021-03-15T18:30:02","slug":"nerve-repair-and-regeneration-market-worth-97-billion-by-2025-key-players-are-medtronic-plc-ireland-boston-scientific-corporation-us","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/nerve-repair-and-regeneration-market-worth-97-billion-by-2025-key-players-are-medtronic-plc-ireland-boston-scientific-corporation-us_534138.html","title":{"rendered":"Nerve Repair and Regeneration Market worth $9.7 billion by 2025 | Key Players are Medtronic, PLC. (Ireland), Boston Scientific Corporation (US)"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/uploads\/1615799921.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Nerve Repair and Regeneration Market worth $9.7 billion by 2025 | Key Players are Medtronic, PLC. (Ireland), Boston Scientific Corporation (US)\" src=\"https:\/\/www.abnewswire.com\/uploads\/1615799921.jpeg\" alt=\"Nerve Repair and Regeneration Market worth $9.7 billion by 2025 | Key Players are Medtronic, PLC. (Ireland), Boston Scientific Corporation (US)\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/p>\n<div class=\"quotes\">\n<div>Key players in the nerve repair and regeneration market are Prominent players in the nerve repair and regeneration market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (Netherlands), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US).<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Nerve Repair and Regeneration Market Size Estimation and Analysis of Wide Range of Growth Opportunities for Industry Players.<\/div>\n<p style=\"text-align: justify;\">According to the new market research report&nbsp;<strong>&#8220;<\/strong><strong>Nerve Repair and Regeneration Market&nbsp;by Products (Nerve Conduits, Nerve Wraps, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Spinal Cord Stimulation, TENS, TMS), Application (Neurorrhaphy, Nerve Grafting, Stem Cell Therapy) and Region &#8211; Global Forecast to 2025&#8243;,&nbsp;<\/strong>published by MarketsandMarkets&trade;,<strong>&nbsp;<\/strong>the global Nerve Repair and Regeneration Market&nbsp;size is projected to reach&nbsp;<span class=\"xn-money\">USD 9.7 billion<\/span>&nbsp;by 2025 from&nbsp;<span class=\"xn-money\">USD 6.3 billion<\/span>&nbsp;in 2020, growing at a CAGR of 9.1% from 2020 to 2025.<\/p>\n<p><strong>Download PDF Brochure:<\/strong><br \/><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=883&amp;utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=883<\/a><\/p>\n<p>The Growth in&nbsp;<strong>Nerve Regeneration Market<\/strong><strong>&nbsp;<\/strong>is driven mainly by high incidence of nerve injuries, the growing prevalence of neurological disorders, and rising government support for neurologic disorder research.<\/p>\n<p><a title=\"Nerve Repair and Regeneration Market\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/nerve-repair-regeneration-market-883.html\"><img decoding=\"async\" src=\"https:\/\/pressrelease.icrowdnewswire.com\/assets\/source\/users\/1902\/nerve-repair-and-regeneration-market.jpg?1615799644310\" alt=\"nerve-repair-and-regeneration-market\" \/><\/a><\/p>\n<p><strong>Neurostimulation and Neuromodulation Devices &nbsp;accounted for the largest share of the market, by product, in 2019<\/p>\n<p><\/strong>By product, the nerve repair market is segmented into neurostimulation and neuromodulation devices and biomaterials. The neurostimulation and neuromodulation devices segment is segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by rising government expenditure for neurologic disorders, and favorable reimbursement .<\/p>\n<p><em>Browse&nbsp;in-depth TOC on<\/em><strong>&nbsp;&#8220;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/nerve-repair-regeneration-market-883.html\" rel=\"nofollow noopener\" target=\"_blank\">Nerve Repair and Regeneration Market<\/a><strong>&#8220;<\/p>\n<p><\/strong><strong>142 &ndash; Tables<br \/><\/strong><strong>43 &ndash; Figures<br \/><\/strong><strong>167 &ndash; Pages<\/p>\n<p><\/strong><strong>By neurostimulation and neuromodulation application, internal neurostimulation and neuromodulation &nbsp;accounted for the largest market share in 2019<\/p>\n<p><\/strong>Based on the neurostimulation and neuromodulation application , the Nerve Regeneration Market is segmented the neurostimulation and neuromodulation devices market is segmented into internal neurostimulation and neuromodulation applications and external neurostimulation and neuromodulation applications. The internal neurostimulation and neuromodulation segment is estimated to register the highest CAGR during the forecast period.&nbsp; This can primarily be attributed to the increasing incidence of neurological disorders across the globe.<\/p>\n<p><strong>By Biomaterials application,&nbsp; direct nerve repair\/neurorrhaphy accounted for the largest market share in 2019<\/p>\n<p><\/strong>Based on application, the biomaterials market is segmented into direct nerve repair\/neurorrhaphy, nerve grafting, and stem cell therapy. In 2019, the direct nerve repair segment accounted for the largest share of the market. This can be attributed to the increasing incidence of neurological disorders across the globe.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Report:<br \/><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=883\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=883<\/a>&nbsp;<\/p>\n<p><\/strong><strong><span class=\"xn-location\">North America<\/span>&nbsp;&nbsp;was the largest regional market for Nerve Repair Market in 2019<\/p>\n<p><\/strong>The Nerve Repair And Regeneration Market is segmented into five major regions, namely,&nbsp;<span class=\"xn-location\">Europe<\/span>,&nbsp;<span class=\"xn-location\">North America<\/span>, the&nbsp;<span class=\"xn-location\">Asia Pacific<\/span>,&nbsp;<span class=\"xn-location\">Latin America<\/span>, and&nbsp;<span class=\"xn-location\">Middle East<\/span>&nbsp;&amp;&nbsp;<span class=\"xn-location\">Africa<\/span>. In 2019, North America&nbsp; accounted for the largest share of the Nerve Regeneration Market, followed by&nbsp;<span class=\"xn-location\">Europe<\/span>. The rising incidence of neurological disorders, favorable reimbursement policies, and the strong presence of industry players in &nbsp;the region are the major factors driving the growth of the market in&nbsp;<span class=\"xn-location\">North America<\/span>.<\/p>\n<p>Some of the major players operating in the global Nerve Repair And Regeneration Market include Medtronic, PLC. (<span class=\"xn-location\">Ireland<\/span>), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), Integra LifeSciences (US), Polyganics (<span class=\"xn-location\">Netherlands<\/span>), NeuroPace, Inc. (US), Soterix Medical, Inc. (US), Nevro Corp (US), Synapse Biomedical, Inc. (US), Aleva Neurotherapeutics (<span class=\"xn-location\">Switzerland<\/span>), Collagen Matrix, Inc. (US), KeriMedical (<span class=\"xn-location\">Switzerland<\/span>), BioWave Corporation (US), NeuroSigma (US), tVNS Technologies GmbH(<span class=\"xn-location\">Germany<\/span>), and GiMer Medical (<span class=\"xn-location\">Taiwan<\/span>).<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=nerve-repair-and-regeneration-market-worth-97-billion-by-2025-key-players-are-medtronic-plc-ireland-boston-scientific-corporation-us\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/nerve-repair-regeneration-market-883.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/nerve-repair-regeneration-market-883.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/nerve-repair-regeneration-market-883.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=nerve-repair-and-regeneration-market-worth-97-billion-by-2025-key-players-are-medtronic-plc-ireland-boston-scientific-corporation-us\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Key players in the nerve repair and regeneration market are Prominent players in the nerve repair and regeneration market include Medtronic, PLC. (Ireland), Boston Scientific Corporation (US), Abbott Laboratories (US), AxoGen, Inc. (US), Baxter International, Inc. (US), LivaNova, PLC. (UK), &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/nerve-repair-and-regeneration-market-worth-97-billion-by-2025-key-players-are-medtronic-plc-ireland-boston-scientific-corporation-us_534138.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,417,406,404],"tags":[],"class_list":["post-534138","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Marketing-Sales","category-Pharmaceuticals-Biotech","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/534138","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=534138"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/534138\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=534138"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=534138"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=534138"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}